No added value of the methionine loading test in assessment for venous thrombosis and cardiovascular disease risk

Thrombosis and Haemostasis

Volumn 95, Issue 2, 2006, Pages 380-385

  Keijzer, Miranda B A ^a   Verhoef, Petra ^b   Borm, George F ^a   Blom, Henk J ^a   den Heijer, Martin ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Homocysteine; Hyperhomocysteinemia; Methionine loading test; ROC curve; Venous thrombosis

Indexed keywords

CHOLESTEROL; CREATININE; HOMOCYSTEINE; METHIONINE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; LOADING TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; ROC CURVE; SMOKING; SYSTOLIC BLOOD PRESSURE; VEIN THROMBOSIS;

AGED; CARDIOVASCULAR DISEASES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; MIDDLE AGED; PRACTICE GUIDELINES; RISK; ROC CURVE; VENOUS THROMBOSIS;

EID: 33645535181     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-07-0498     Document Type: Article

References (30)

1. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002; 288: 2015-22.
2. den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005; 3: 292-9.
3. Refsum H, Smith AD, Ueland PM et al. Facts and recommendations about total homocysteine determinations: An experts opinion. Clin Chem 2004; 50: 3-32.
4. Stanger O, Hermann W, Pietrzik K et al. D.A.CH.-Liga Homocysteine (German, Austrian and Swiss homocysteine society): Consensus paper on the rational clinical use of homocysteine, folic acid, and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 2003; 41: 1392-403.
5. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases. A statement for healthcare professionals from the Nutrition Committee American Heart Association. Circulation 1999; 99: 178-82.
6. The Netherlands Heart Foundation. [Guidelines Homocysteïne and Cardiovascular Disease]. Dutch. May 2001.
7. Van der Griend R, Haas FJLM, Duran M et al. Methionine loading test is necessary for detection of hyperhomocysteinemia. J Lab Clin Med 1998; 132: 67-72.
8. Bostom AG, Jacques PF, Nadeau MR et al. Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from The NHLBI Family Heart Study. Atherosclerosis 1995; 116: 147-51.
9. Cattaneo M, Martinelli I, Mannucci PM. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis (letter). N Engl J Med 1996; 13: 974-75.
10. Graham IM, Daly LE, Refsum HM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775-81.
11. Fowler B, Sardharwalla IB, Robins AJ. The detection of heterozygotes for homocystinuria by oral loading with L-methionine, Biochem J 1971; 122: 23-4.
12. McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis 1975; 22: 215-27.
13. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976; 57: 1079-82.
14. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ et al. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35-41.
15. Den Heijer M, Rosendaal FR, Blom HJ et al. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998; 80: 874-7.
16. Keijzer MBAJ, den Heijer M, Blom HJ et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 2002; 88: 723-8.
17. Boushey CJ, Beresford SAA, Omenn GS et al, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes, JAMA 1995; 274: 1049-57.
18. Den Heijer M, Blom HJ, Gerrits WBJ et al. Is byperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet 1995; 345: 882-5.
19. Verhoef P, Kok FJ, Kruyssen DA et al. Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 989-95.
20. Den Heijer M, Bos GMJ, Brouwer IA et al. Variability of the methionine loading test: no effect of a low protein diet. Ann Clin Biochem, 1996; 33: 551-4.
21. Te Poele-Pothoff MT, van den Berg M, Franken DG et al. Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem 1995; 32: 218-20.
22. Pepe MS, Janes H, Longton G et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159: 882-90.
23. Den Heijer M, Te Poele-Potthof M, Blom HJ. Hyperhomocysteinemia: risk factor or consequence of venous thrombosis? J Inherit Metab Dis 2003: 26: suppl 1.
24. Smulders YM. The (non-)sense of the methionine loading test for detecting hyperhomocysteinaemia. Neth J Med 2000; 57: 172-3.
25. Van de Laak MF, Grobbee DE, Van der Griend R et al. A 2-step strategy to reduce the need for methionine-loading tests to diagnose hyperhomocysteinemia. J Lab Clin Med 2003; 142: 121-7.
26. Marongiu F, Fenu L, Pisu G et al. Hyperhomocysteinemia: could the post-methionine oral loading test sometimes be avoided? Haematologica 2003; 88: 186-91.
27. Ubbink JB. Becker PJ, Delport R et al. Variability of post-methionine load plasma homocysteine assays. Clin Chim Acta 2003; 330: 111-9.
28. De Jonge R, Griffioen PH, van Zelst B et al. Evaluation of a shorter methionine loading test. Clin Chem Lab Med 2004; 42: 1027-31.
29. Bostom AG, Roubenoff R, Dellaripa P et al, Validation of abbreviated oral methionine-loading test. Clin Chem 1995; 41: 948-9.
30. Wald DS, Law M, Morris JK. The dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screening. Eur J Cardiovasc Prevention Rehab 2004; 11: 250-3.